Trader consensus on Polymarket prices a 73.5% implied probability for the CDC issuing a Level 3 "Reconsider Nonessential Travel" notice for any disease by December 31, 2026, driven by escalating U.S. measles outbreaks—now exceeding 1,700 confirmed cases across 17 new outbreaks this year, per CDC surveillance—and recent Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, and chikungunya in Mayotte. These developments signal heightened global transmission risks amid declining vaccination coverage and seasonal pathogen upticks, with historical precedents showing rapid notice escalations during similar surges. No Level 3 notices are active, but upcoming CDC FluView reports and WHO epidemiological updates could prompt shifts as winter respiratory season approaches.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गयासीडीसी ने 31 दिसंबर तक लेवल 3 की चेतावनी जारी कर दी है?
सीडीसी ने 31 दिसंबर तक लेवल 3 की चेतावनी जारी कर दी है?
हाँ
$112,107 वॉल्यूम
$112,107 वॉल्यूम
31 दिस, 2026
हाँ
$112,107 वॉल्यूम
$112,107 वॉल्यूम
31 दिस, 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket prices a 73.5% implied probability for the CDC issuing a Level 3 "Reconsider Nonessential Travel" notice for any disease by December 31, 2026, driven by escalating U.S. measles outbreaks—now exceeding 1,700 confirmed cases across 17 new outbreaks this year, per CDC surveillance—and recent Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, and chikungunya in Mayotte. These developments signal heightened global transmission risks amid declining vaccination coverage and seasonal pathogen upticks, with historical precedents showing rapid notice escalations during similar surges. No Level 3 notices are active, but upcoming CDC FluView reports and WHO epidemiological updates could prompt shifts as winter respiratory season approaches.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
बाज़ार खुला: Jan 19, 2026, 3:15 PM ET
वॉल्यूम
$112,107समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket prices a 73.5% implied probability for the CDC issuing a Level 3 "Reconsider Nonessential Travel" notice for any disease by December 31, 2026, driven by escalating U.S. measles outbreaks—now exceeding 1,700 confirmed cases across 17 new outbreaks this year, per CDC surveillance—and recent Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, and chikungunya in Mayotte. These developments signal heightened global transmission risks amid declining vaccination coverage and seasonal pathogen upticks, with historical precedents showing rapid notice escalations during similar surges. No Level 3 notices are active, but upcoming CDC FluView reports and WHO epidemiological updates could prompt shifts as winter respiratory season approaches.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
वॉल्यूम
$112,107समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus on Polymarket prices a 73.5% implied probability for the CDC issuing a Level 3 "Reconsider Nonessential Travel" notice for any disease by December 31, 2026, driven by escalating U.S. measles outbreaks—now exceeding 1,700 confirmed cases across 17 new outbreaks this year, per CDC surveillance—and recent Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, and chikungunya in Mayotte. These developments signal heightened global transmission risks amid declining vaccination coverage and seasonal pathogen upticks, with historical precedents showing rapid notice escalations during similar surges. No Level 3 notices are active, but upcoming CDC FluView reports and WHO epidemiological updates could prompt shifts as winter respiratory season approaches.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया
बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न